Stockhead TV
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Radiopharm Theranostics.
RELATED STOCKHEAD STORIES
News
ASX Lunch Wrap: ASX wobbles despite mining gains, and Goldman warns of correction
Health & Biotech
Health Check: Radiopharm dials up after gaining new major shareholder
Stockhead TV
Break it Down: Radiopharm Theranostics progresses along path to help heal HER-2 cancer
Health & Biotech
Health Check: ASX sleep company emerges from slumber with a revenue and earnings upgrade
Health & Biotech
Health Check: Hearts aflutter as Echo IQ aces deal with major US teaching hospital
Stockhead TV
Tony’s Takeaway: Biotech buffet on the ASX
Health & Biotech
Health Check: Island Pharmaceuticals raises funds to put the mozz on dengue fever outbreak
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps Lunch Wrap: Who’s been busted playing dress-ups in the US this week?
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Radiopharmaceutical emerges as the hottest space in biotech; here’s what it means for Clarity Pharma
Health & Biotech
ASX Health Stocks: EMV gets strategic US$15m investment from NYSE-listed giant
Health & Biotech
ASX Health Stocks: Radiopharm’s results published; ProMedicus launches on Apple Vision Pro
Health & Biotech
Check Up: Earnings season is almost here. Here’s how ASX biotech investors should read the 4C Report
Experts
Money Talks: Keep an eye on these tasty precious metal and biotech plays in 2024
Health & Biotech
ASX Health Stocks: Opthea up 13pc on $85m funding from giant investment firm Carlyle, new investor
Health & Biotech